{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:20:10Z","timestamp":1784035210989,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-026-00833-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:01:59Z","timestamp":1783414919000},"page":"638-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mavacamten shows broad benefit in human and mouse models of MYBPC3-related hypertrophic cardiomyopathy"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-2081","authenticated-orcid":false,"given":"Laura","family":"Sen-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Fern\u00e1ndez-Trasancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1.","family":"L\u00f3pez-Unzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-0984","authenticated-orcid":false,"given":"Agata","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Zafra-Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiven","family":"Srikantharajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-2308","authenticated-orcid":false,"given":"Divya","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel N.","family":"Kuehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Labrador-Cantarero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"S\u00e1nchez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-780X","authenticated-orcid":false,"given":"Mar\u00eda Rosaria","family":"Pricolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vel\u00e1zquez-Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0375-0969","authenticated-orcid":false,"given":"Luc\u00eda","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Sicilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-7216","authenticated-orcid":false,"given":"Jos\u00e9 \u00c1ngel","family":"Nicol\u00e1s-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Schlossarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Cuss\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-3231","authenticated-orcid":false,"given":"Manuel","family":"Desco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Villalba-Orero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-7959","authenticated-orcid":false,"given":"Gabriela","family":"Guzm\u00e1n-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6721-3487","authenticated-orcid":false,"given":"Roberto","family":"Barriales-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5092","authenticated-orcid":false,"given":"Jes\u00fas","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-1664","authenticated-orcid":false,"given":"F\u00e1tima","family":"S\u00e1nchez-Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5513-555X","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter P.","family":"de Tombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-5820","authenticated-orcid":false,"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-4254","authenticated-orcid":false,"given":"James A.","family":"Spudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Ruppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-0517","authenticated-orcid":false,"given":"Florian","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cazorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-4221","authenticated-orcid":false,"given":"Anthony L.","family":"Hessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0542-0170","authenticated-orcid":false,"given":"Jorge","family":"Alegre-Cebollada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"833_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J. & Braunwald, E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res. 121, 749\u2013770 (2017).","journal-title":"Circ. Res."},{"key":"833_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clinimag.2023.01.003","volume":"95","author":"N Goyal","year":"2023","unstructured":"Goyal, N. et al. Hypertrophic cardiomyopathy \u2013 phenotypic variations beyond wall thickness. Clin. Imaging 95, 80\u201389 (2023).","journal-title":"Clin. Imaging"},{"key":"833_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo7622","volume":"9","author":"S Nag","year":"2023","unstructured":"Nag, S., Gollapudi, S. K., Del Rio, C. L., Spudich, J. A. & McDowell, R. Mavacamten, a precision medicine for hypertrophic cardiomyopathy: from a motor protein to patients. Sci. Adv. 9, eabo7622 (2023).","journal-title":"Sci. Adv."},{"key":"833_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/1873-3468.14301","volume":"596","author":"C Suay-Corredera","year":"2022","unstructured":"Suay-Corredera, C. & Alegre-Cebollada, J. The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP-C. FEBS Lett. 596, 703\u2013746 (2022).","journal-title":"FEBS Lett."},{"key":"833_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","volume":"128","author":"AJ Marian","year":"2021","unstructured":"Marian, A. J. Molecular genetic basis of hypertrophic cardiomyopathy. Circ. Res. 128, 1533\u20131553 (2021).","journal-title":"Circ. Res."},{"key":"833_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46957-7","volume":"15","author":"AL Hessel","year":"2024","unstructured":"Hessel, A. L. et al. Myosin-binding protein C regulates the sarcomere lattice and stabilizes the OFF states of myosin heads. Nat. Commun. 15, 2628 (2024).","journal-title":"Nat. Commun."},{"key":"833_CR7","doi-asserted-by":"publisher","first-page":"bio057646","DOI":"10.1242\/bio.057646","volume":"10","author":"M Schmid","year":"2021","unstructured":"Schmid, M. & Toepfer, C. N. Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics. Biol. Open 10, bio057646 (2021).","journal-title":"Biol. Open"},{"key":"833_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10555-9","volume":"10","author":"AS Adhikari","year":"2019","unstructured":"Adhikari, A. S. et al. beta-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity. Nat. Commun. 10, 2685 (2019).","journal-title":"Nat. Commun."},{"key":"833_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax0069","volume":"6","author":"SS Sarkar","year":"2020","unstructured":"Sarkar, S. S. et al. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin. Sci. Adv. 6, eaax0069 (2020).","journal-title":"Sci. Adv."},{"key":"833_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00424-019-02259-2","volume":"471","author":"JA Spudich","year":"2019","unstructured":"Spudich, J. A. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Pflugers Arch. 471, 701\u2013717 (2019).","journal-title":"Pflugers Arch."},{"key":"833_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2016.03.009","volume":"94","author":"JW McNamara","year":"2016","unstructured":"McNamara, J. W. et al. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. J. Mol. Cell. Cardiol. 94, 65\u201371 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"833_CR12","doi-asserted-by":"publisher","first-page":"e0180064","DOI":"10.1371\/journal.pone.0180064","volume":"12","author":"JW McNamara","year":"2017","unstructured":"McNamara, J. W. et al. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PLOS ONE 12, e0180064 (2017).","journal-title":"PLOS ONE"},{"key":"833_CR13","doi-asserted-by":"publisher","first-page":"eaat1199","DOI":"10.1126\/scitranslmed.aat1199","volume":"11","author":"CN Toepfer","year":"2019","unstructured":"Toepfer, C. N. et al. Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin. Sci. Transl. Med. 11, eaat1199 (2019).","journal-title":"Sci. Transl. Med."},{"key":"833_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","volume":"351","author":"EM Green","year":"2016","unstructured":"Green, E. M. et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351, 617\u2013621 (2016).","journal-title":"Science"},{"key":"833_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","volume":"19","author":"SJ Lehman","year":"2022","unstructured":"Lehman, S. J., Crocini, C. & Leinwand, L. A. Targeting the sarcomere in inherited cardiomyopathies. Nat. Rev. Cardiol. 19, 353\u2013363 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"833_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto, I. et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 396, 759\u2013769 (2020).","journal-title":"Lancet"},{"key":"833_CR17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","volume":"141","author":"CN Toepfer","year":"2020","unstructured":"Toepfer, C. N. et al. Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation 141, 828\u2013842 (2020).","journal-title":"Circulation"},{"key":"833_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100854","volume":"297","author":"C Suay-Corredera","year":"2021","unstructured":"Suay-Corredera, C. et al. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. J. Biol. Chem. 297, 100854 (2021).","journal-title":"J. Biol. Chem."},{"key":"833_CR19","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1021\/acsnano.1c02242","volume":"15","author":"C Suay-Corredera","year":"2021","unstructured":"Suay-Corredera, C. et al. Nanomechanical phenotypes in cardiac myosin-binding protein C mutants that cause hypertrophic cardiomyopathy. ACS Nano 15, 10203\u201310216 (2021).","journal-title":"ACS Nano"},{"key":"833_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.109.216291","volume":"106","author":"AJ Saltzman","year":"2010","unstructured":"Saltzman, A. J. et al. Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy. Circ. Res. 106, 1549\u20131552 (2010).","journal-title":"Circ. Res."},{"key":"833_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/CIRCGEN.120.002929","volume":"13","author":"AS Helms","year":"2020","unstructured":"Helms, A. S. et al. Spatial and functional distribution of MYBPC3 pathogenic variants and clinical outcomes in patients with hypertrophic cardiomyopathy. Circ. Genom. Precis. Med. 13, 396\u2013405 (2020).","journal-title":"Circ. Genom. Precis. Med."},{"key":"833_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","volume":"108","author":"SP Harris","year":"2011","unstructured":"Harris, S. P., Lyons, R. G. & Bezold, K. L. In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ. Res. 108, 751\u2013764 (2011).","journal-title":"Circ. Res."},{"key":"833_CR23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0735-1097(01)01509-1","volume":"38","author":"DS Lim","year":"2001","unstructured":"Lim, D. S., Roberts, R. & Marian, A. J. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J. Am. Coll. Cardiol. 38, 1175\u20131180 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"833_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01043-3","volume":"13","author":"J Pei","year":"2021","unstructured":"Pei, J. et al. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations. Clin. Epigenetics 13, 61 (2021).","journal-title":"Clin. Epigenetics"},{"key":"833_CR25","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri, S. et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation 144, 1714\u20131731 (2021).","journal-title":"Circulation"},{"key":"833_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-022-00490-3","volume":"9","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics. Cell Discov. 9, 6 (2023).","journal-title":"Cell Discov."},{"key":"833_CR27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3389\/fphys.2018.01442","volume":"9","author":"E Farrell","year":"2018","unstructured":"Farrell, E. et al. Transcriptome analysis of cardiac hypertrophic growth in MYBPC3-null mice suggests early responders in hypertrophic remodeling. Front. Physiol. 9, 1442 (2018).","journal-title":"Front. Physiol."},{"key":"833_CR28","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi, P. et al. Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923\u20132931 (2001).","journal-title":"Circulation"},{"key":"833_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1143858","volume":"14","author":"M Noureddine","year":"2023","unstructured":"Noureddine, M. & Gehmlich, K. Structural and signaling proteins in the Z-disk and their role in cardiomyopathies. Front. Physiol. 14, 1143858 (2023).","journal-title":"Front. Physiol."},{"key":"833_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jacc.2008.12.082","volume":"54","author":"T Arimura","year":"2009","unstructured":"Arimura, T. et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 54, 334\u2013342 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"833_CR31","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1172\/JCI70108","volume":"124","author":"DC Christodoulou","year":"2014","unstructured":"Christodoulou, D. C. et al. 5\u2032 RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. J. Clin. Invest. 124, 1364\u20131370 (2014).","journal-title":"J. Clin. Invest."},{"key":"833_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/CIRCRESAHA.124.324387","volume":"135","author":"N Pietsch","year":"2024","unstructured":"Pietsch, N. et al. Chronic activation of tubulin tyrosination improves heart function. Circ. Res. 135, 910\u2013932 (2024).","journal-title":"Circ. Res."},{"key":"833_CR33","doi-asserted-by":"publisher","first-page":"E4386","DOI":"10.1073\/pnas.1716498115","volume":"115","author":"S Matsuyama","year":"2018","unstructured":"Matsuyama, S. et al. Interaction between cardiac myosin-binding protein C and formin Fhod3. Proc. Natl Acad. Sci. USA 115, E4386\u2013E4395 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"833_CR34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","volume":"48","author":"D Barefield","year":"2010","unstructured":"Barefield, D. & Sadayappan, S. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J. Mol. Cell. Cardiol. 48, 866\u2013875 (2010).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"833_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1602445","volume":"3","author":"R Mamidi","year":"2017","unstructured":"Mamidi, R., Gresham, K. S., Li, J. & Stelzer, J. E. Cardiac myosin binding protein-C Ser302 phosphorylation regulates cardiac \u03b2-adrenergic reserve. Sci. Adv. 3, e1602445 (2017).","journal-title":"Sci. Adv."},{"key":"833_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardiores.2005.11.009","volume":"69","author":"O Cazorla","year":"2006","unstructured":"Cazorla, O. et al. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc. Res. 69, 370\u2013380 (2006).","journal-title":"Cardiovasc. Res."},{"key":"833_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101485","volume":"298","author":"S Ponnam","year":"2022","unstructured":"Ponnam, S. & Kampourakis, T. Microscale thermophoresis suggests a new model of regulation of cardiac myosin function via interaction with cardiac myosin-binding protein C. J. Biol. Chem. 298, 101485 (2022).","journal-title":"J. Biol. Chem."},{"key":"833_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2025.02.002","volume":"200","author":"AC Greenman","year":"2025","unstructured":"Greenman, A. C., Sadler, R. L. & Harris, S. P. Autoinhibition of cMyBP-C by its middle domains. J. Mol. Cell. Cardiol. 200, 82\u201392 (2025).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"833_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nsmb.3408","volume":"24","author":"S Nag","year":"2017","unstructured":"Nag, S. et al. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat. Struct. Mol. Biol. 24, 525\u2013533 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"833_CR40","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3390\/ijms23063052","volume":"23","author":"W Ma","year":"2022","unstructured":"Ma, W. & Irving, T. C. Small angle X-ray diffraction as a tool for structural characterization of muscle disease. Int. J. Mol. Sci. 23, 3052 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"833_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae039","volume":"3","author":"VP Jani","year":"2024","unstructured":"Jani, V. P. et al. The structural OFF and ON states of myosin can be decoupled from the biochemical super- and disordered-relaxed states. PNAS Nexus 3, pgae039 (2024).","journal-title":"PNAS Nexus"},{"key":"833_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","volume":"63","author":"L Carrier","year":"2004","unstructured":"Carrier, L. et al. Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc. Res. 63, 293\u2013304 (2004).","journal-title":"Cardiovasc. Res."},{"key":"833_CR43","doi-asserted-by":"publisher","first-page":"e70606","DOI":"10.14814\/phy2.70606","volume":"13","author":"MN Kuehn","year":"2025","unstructured":"Kuehn, M. N. et al. Mavacamten facilitates myosin head ON-to-OFF transitions and shortens thin filament length in relaxed skeletal muscle. Physiological Reports 13, e70606 (2025).","journal-title":"Physiological Reports"},{"key":"833_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.stemcr.2018.11.015","volume":"12","author":"R Cohn","year":"2019","unstructured":"Cohn, R. et al. A contraction stress model of hypertrophic cardiomyopathy due to sarcomere mutations. Stem Cell Reports 12, 71\u201383 (2019).","journal-title":"Stem Cell Reports"},{"key":"833_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","volume":"165","author":"J Davis","year":"2016","unstructured":"Davis, J. et al. A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy. Cell 165, 1147\u20131159 (2016).","journal-title":"Cell"},{"key":"833_CR46","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa2505927","volume":"393","author":"MY Desai","year":"2025","unstructured":"Desai, M. Y. et al. Mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy. N. Engl. J. Med. 393, 961\u2013972 (2025).","journal-title":"N. Engl. J. Med."},{"key":"833_CR47","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.jacc.2025.08.019","volume":"86","author":"MY Desai","year":"2025","unstructured":"Desai, M. Y. et al. Echocardiographic changes with mavacamten in nonobstructive hypertrophic cardiomyopathy: exploratory insights from the ODYSSEY-HCM trial. J. Am. Coll. Cardiol. 86, 2434\u20132449 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"833_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yjmcc.2024.07.007","volume":"195","author":"J Mertens","year":"2024","unstructured":"Mertens, J. et al. The W792R HCM missense mutation in the C6 domain of cardiac myosin binding protein-C increases contractility in neonatal mouse myocardium. J. Mol. Cell. Cardiol. 195, 14\u201323 (2024).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"833_CR49","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1021\/bi500784g","volume":"53","author":"XL Zhang","year":"2014","unstructured":"Zhang, X. L., De, S., McIntosh, L. P. & Paetzel, M. Structural characterization of the C3 domain of cardiac myosin binding protein C and its hypertrophic cardiomyopathy-related R502W mutant. Biochemistry 53, 5332\u20135342 (2014).","journal-title":"Biochemistry"},{"key":"833_CR50","doi-asserted-by":"publisher","first-page":"18763","DOI":"10.1073\/pnas.1413922112","volume":"111","author":"T Kampourakis","year":"2014","unstructured":"Kampourakis, T., Yan, Z., Gautel, M., Sun, Y. B. & Irving, M. Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells. Proc. Natl Acad. Sci. USA 111, 18763\u201318768 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"833_CR51","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.125.074120","volume":"152","author":"A Xu","year":"2025","unstructured":"Xu, A. et al. Hypercontractility and oxidative stress drive creatine kinase dysfunction in hypertrophic cardiomyopathy. Circulation 152, 1705\u20131727 (2025).","journal-title":"Circulation"},{"key":"833_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41586-023-06691-4","volume":"623","author":"D Dutta","year":"2023","unstructured":"Dutta, D., Nguyen, V., Campbell, K. S., Padron, R. & Craig, R. Cryo-EM structure of the human cardiac myosin filament. Nature 623, 853\u2013862 (2023).","journal-title":"Nature"},{"key":"833_CR53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41586-023-06690-5","volume":"623","author":"D Tamborrini","year":"2023","unstructured":"Tamborrini, D. et al. Structure of the native myosin filament in the relaxed cardiac sarcomere. Nature 623, 863\u2013871 (2023).","journal-title":"Nature"},{"key":"833_CR54","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1093\/eurheartj\/ehaf324","volume":"46","author":"T Baka","year":"2025","unstructured":"Baka, T. et al. Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. Eur. Heart J. 46, 4105\u20134119 (2025).","journal-title":"Eur. Heart J."},{"key":"833_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.101449","volume":"11","author":"S Mohran","year":"2026","unstructured":"Mohran, S. et al. Myosin modulator aficamten inhibits force by altering myosin\u2019s biochemical activity without changing thick filament structure. JACC Basic Transl. Sci. 11, 101449 (2026).","journal-title":"JACC Basic Transl. Sci."},{"key":"833_CR56","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202113029","volume":"154","author":"JG Ovejero","year":"2022","unstructured":"Ovejero, J. G. et al. Cooling intact and demembranated trabeculae from rat heart releases myosin motors from their inhibited conformation. J. Gen. Physiol. 154, e202113029 (2022).","journal-title":"J. Gen. Physiol."},{"key":"833_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2342-10-1","volume":"10","author":"E Heiberg","year":"2010","unstructured":"Heiberg, E. et al. Design and validation of Segment\u2014freely available software for cardiovascular image analysis. BMC Med. Imaging 10, 1 (2010).","journal-title":"BMC Med. Imaging"},{"key":"833_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"833_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"833_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"833_CR61","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1074\/mcp.M700239-MCP200","volume":"7","author":"S Martinez-Bartolome","year":"2008","unstructured":"Martinez-Bartolome, S. et al. Properties of average score distributions of SEQUEST: the probability ratio method. Mol. Cell. Proteomics 7, 1135\u20131145 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"833_CR62","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller, A., Nesvizhskii, A. I., Kolker, E. & Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal. Chem. 74, 5383\u20135392 (2002).","journal-title":"Anal. Chem."},{"key":"833_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/pr700747q","volume":"7","author":"H Choi","year":"2008","unstructured":"Choi, H. & Nesvizhskii, A. I. False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J. Proteome Res. 7, 47\u201350 (2008).","journal-title":"J. Proteome Res."},{"key":"833_CR64","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/pr5007284","volume":"14","author":"E Bonzon-Kulichenko","year":"2015","unstructured":"Bonzon-Kulichenko, E., Garcia-Marques, F., Trevisan-Herraz, M. & Vazquez, J. Revisiting peptide identification by high-accuracy mass spectrometry: problems associated with the use of narrow mass precursor windows. J. Proteome Res. 14, 700\u2013710 (2015).","journal-title":"J. Proteome Res."},{"key":"833_CR65","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1021\/pr4006958","volume":"13","author":"P Navarro","year":"2014","unstructured":"Navarro, P. et al. General statistical framework for quantitative proteomics by stable isotope labeling. J. Proteome Res. 13, 1234\u20131247 (2014).","journal-title":"J. Proteome Res."},{"key":"833_CR66","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1074\/mcp.M115.055905","volume":"15","author":"F Garcia-Marques","year":"2016","unstructured":"Garcia-Marques, F. et al. A novel systems-biology algorithm for the analysis of coordinated protein responses using quantitative proteomics. Mol. Cell. Proteomics 15, 1740\u20131760 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"833_CR67","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.csbj.2023.12.034","volume":"23","author":"JM Rodriguez","year":"2024","unstructured":"Rodriguez, J. M. et al. iSanXoT: a standalone application for the integrative analysis of mass spectrometry-based quantitative proteomics data. Comput. Struct. Biotechnol. J. 23, 452\u2013459 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"833_CR68","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.108.798983","volume":"119","author":"S Sadayappan","year":"2009","unstructured":"Sadayappan, S. et al. Cardiac myosin binding protein-C phosphorylation in a beta-myosin heavy chain background. Circulation 119, 1253\u20131262 (2009).","journal-title":"Circulation"},{"key":"833_CR69","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1107\/S1600577524006167","volume":"31","author":"J Jiratrakanvong","year":"2024","unstructured":"Jiratrakanvong, J. et al. MuscleX: data analysis software for fiber diffraction patterns from muscle. J. Synchrotron Radiat. 31, 1401\u20131408 (2024).","journal-title":"J. Synchrotron Radiat."},{"key":"833_CR70","first-page":"e54052","volume":"111","author":"JP Dougherty","year":"2016","unstructured":"Dougherty, J. P., Springer, D. A. & Gershengorn, M. C. The treadmill fatigue test: a simple, high-throughput assay of fatigue-like behavior for the mouse. J. Vis. Exp. 111, e54052 (2016).","journal-title":"J. Vis. Exp."},{"key":"833_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"X Lian","year":"2013","unstructured":"Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162\u2013175 (2013).","journal-title":"Nat. Protoc."},{"key":"833_CR72","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/nprot.2017.033","volume":"12","author":"K Breckwoldt","year":"2017","unstructured":"Breckwoldt, K. et al. Differentiation of cardiomyocytes and generation of human engineered heart tissue. Nat. Protoc. 12, 1177\u20131197 (2017).","journal-title":"Nat. Protoc."},{"key":"833_CR73","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","volume":"122","author":"L Sala","year":"2018","unstructured":"Sala, L. et al. MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circ. Res. 122, e5\u2013e16 (2018).","journal-title":"Circ. Res."},{"key":"833_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2013.01.001","volume":"57","author":"T Kraft","year":"2013","unstructured":"Kraft, T. et al. Familial hypertrophic cardiomyopathy: Functional effects of myosin mutation R723G in cardiomyocytes. J. Mol. Cell. Cardiol. 57, 13\u201322 (2013).","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00833-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:02:08Z","timestamp":1784034128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-026-00833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1038\/s44161-026-00833-3","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B.-V. is member of advisory boards and has received speaker fees from Bristol Myers Squibb (BMS), Sanofi, Cytokinetics, Alnaylam, Chiesi and Pfizer. L. Carrier is advisor and shareholder of DiNAQOR AG developing a\n                      MYBPC3\n                      -based gene therapy for HCM. J.A.S. is cofounder and on the Scientific Advisory Board of Cytokinetics, Inc, a company developing small molecule therapeutics for treatment of hypertrophic cardiomyopathy. The laboratory of J.A.-C. received funding from Myokardia (now BMS) between 2020 and 2021 for the project \u2018Titin Allelic Discrimination to Uncover Pathophysiology Mechanisms in DCM\u2019. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}